Why do we need to sell? So these great products can get to those who need them sooner rather than later. Neuren at the moment has little expertise in getting a drug through Phase 3, and the ASX is no place for a company with this potential to be. How many other great ASX listed success stories have there been in the biotech field? Oh, that's right. None. And for good reason. Sell and grow, or hold and wither. Take your pick.
NEU Price at posting:
$24.98 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)